ChartMill · Jul 24, 2026
On Friday, there are stocks with unusual volume. Let's take a look.
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
AD
NASDAQ · ADVB
Advanced Biomed Inc. Common Stock
Healthcare · Medical - Diagnostics & Research
$8.85
Up+$0.35 (+4.12%)
Updated Sep 11, 2026, 2:46 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.4M
- P/E ratio
- 17.36
- Dividend yield
- 0.00%
- 52-week range
- $3.61 – $24.23
- Volume
- 121.15K
- Avg. volume
- 52.79K
Price performance
ADVB price history
1M range · 20 trading sessions · Daily adjusted prices
ADVB closed at $8.85 after 20 trading sessions, up 3.15% for the selected period.
- Last close
- $8.85
- Period change
- +3.15%
- Period low
- $8.02
- Period high
- $10.44
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $8.29 | $9.0848 | $8.29 | $8.85 | 121.15K |
| Sep 9, 2026 | $8.84 | $9.04 | $8.38 | $8.50 | 84.74K |
| Sep 8, 2026 | $9.29 | $9.37 | $8.65 | $8.98 | 39.86K |
| Sep 4, 2026 | $9.33 | $9.44 | $9.1021 | $9.335 | 66.46K |
| Sep 3, 2026 | $9.76 | $9.97 | $9.02 | $9.40 | 207.83K |
| Sep 2, 2026 | $10.41 | $10.451 | $9.36 | $9.77 | 86.47K |
| Sep 1, 2026 | $9.36 | $10.80 | $9.20 | $10.44 | 369.64K |
| Aug 31, 2026 | $9.54 | $9.94 | $8.695 | $9.45 | 147.04K |
| Aug 28, 2026 | $9.38 | $9.86 | $9.0101 | $9.70 | 276.76K |
| Aug 27, 2026 | $9.05 | $9.75 | $8.60 | $9.57 | 371.87K |
| Aug 26, 2026 | $9.00 | $10.01 | $8.46 | $9.24 | 570.87K |
| Aug 25, 2026 | $7.92 | $9.39 | $7.6317 | $9.18 | 595.92K |
| Aug 24, 2026 | $7.98 | $8.02 | $7.425 | $8.02 | 190.81K |
| Aug 21, 2026 | $7.84 | $8.14 | $7.20 | $8.14 | 82.89K |
| Aug 20, 2026 | $8.50 | $8.98 | $8.00 | $8.19 | 196.8K |
| Aug 19, 2026 | $8.43 | $9.4103 | $8.35 | $8.35 | 218.82K |
| Aug 18, 2026 | $8.16 | $9.06 | $8.00 | $8.72 | 182.76K |
| Aug 17, 2026 | $8.77 | $9.225 | $7.975 | $8.23 | 176.01K |
| Aug 14, 2026 | $8.80 | $9.4999 | $8.4344 | $8.95 | 486.49K |
| Aug 13, 2026 | $7.40 | $8.88 | $7.40 | $8.58 | 43.64K |
Latest ADVB news
The latest Smart Investors Daily articles mentioning ADVB.
Stock researchCompany · Overview
ADVB research
Overview
Company profile and research snapshot.
Company profile
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Jul 24, 2026
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 28.3% to $21.53 during Friday's pre-market session. The company's market cap stands at $27.4 million. Akanda (NASDAQ:AKAN) shares increased by
ChartMill · Jul 21, 2026
In today's session, these stocks are experiencing unusual volume.
Discover the stocks with unexpected trading volume in today's session on the US markets.
Benzinga · Jul 21, 2026
Advanced Biomed Stock Is Surging: Here's Why It Is Trending
Advanced Biomed stock surges after withdrawing its SEC Form S-1, removing a planned securities offering and potential shareholder dilution.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
